Decision Aid for Lung Cancer

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byDonald Sullivan

Age: Any Age

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: OHSU Knight Cancer Institute

No Placebo Group

Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

This trial tests a tool that helps lung cancer patients understand their treatment options and make decisions with their doctors. It aims to improve patient knowledge, reduce uncertainty, and enhance communication. The study evaluates the tool's effectiveness.

Research Team

Donald Sullivan

Principal Investigator

OHSU Knight Cancer Institute

Eligibility Criteria

This trial is for English-speaking individuals with a life expectancy over 6 months who have completed treatment or are undergoing diagnostic work-up for suspected or confirmed stage I-IV non-small cell lung cancer. They must also be cognitively able to participate, as indicated by a score above 3 on a specific cognitive screener.

Inclusion Criteria

I am being tested for suspected lung cancer at any stage.

You are expected to live for at least 6 more months.

I have completed treatment for early or advanced non-small cell lung cancer.

See 2 more

Treatment Details

Interventions

Decision Aid (Behavioural Intervention)

Trial OverviewThe study tests the effectiveness of a decision aid designed to improve decision-making in patients with non-small cell lung cancer. It aims to see if this tool helps patients understand their condition better and make more informed choices about their care alongside their doctors.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (conversation tool)Experimental Treatment2 Interventions

Patients receive the conversation tool.

Group II: Arm II (usual care)Active Control2 Interventions

Patients receive usual care.